SCHEMBL1930907

SCHEMBL1930907

CC(=O)c1ccc(OCCOC2CCCCO2)cc1

nearest known ligand 0.70

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.70
KMT2A Q03164 2/20 0.70
L3MBTL1 Q9Y468 1/20 0.55
HRH3 Q9Y5N1 1/20 0.55
GAA P10253 1/20 0.54
ALDH1A1 P00352 2/20 0.48
MAPT P10636 1/20 0.48
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
CREBBP Q92793 1/20 0.44
KDM4C Q9H3R0 1/20 0.44
HRH2 P25021 1/20 0.44
HRH1 P35367 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1813642 0.90 MEN1 (0.73) MEN1KMT2AHRH3GAAALDH1A1
SCHEMBL2981986 0.88 MEN1 (0.88) MEN1KMT2AL3MBTL1HRH3ALDH1A1
SCHEMBL2980200 0.88 KMT2A (0.67) MEN1KMT2AL3MBTL1HRH3ALDH1A1
SCHEMBL28475387 0.86 MEN1 (0.65) MEN1KMT2AL3MBTL1HRH3GAA
SCHEMBL28477489 0.85 MEN1 (0.64) MEN1KMT2AL3MBTL1HRH3GAA
SCHEMBL16097702 0.84 MEN1 (0.63) MEN1KMT2AL3MBTL1HRH3MAPT
SCHEMBL8509832 0.84 MEN1 (0.65) MEN1KMT2AL3MBTL1HRH3ALDH1A1
SCHEMBL18417689 0.83 MEN1 (0.61) MEN1KMT2AHRH3SMN1; SMN2KDM4E
SCHEMBL18417679 0.83 MEN1 (0.61) MEN1KMT2AL3MBTL1HRH3SMN1; SMN2
SCHEMBL20579223 0.83 MEN1 (0.64) MEN1KMT2AL3MBTL1HRH3GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10351523-B2 UV-absorbing compounds with at least one reactive hydrogen ISP INVESTMENTS LLC 2019-07-16 US disclosed
US-10351523-B2 UV-absorbing compounds with at least one reactive hydrogen ISP INVESTMENTS LLC 2019-07-16 US disclosed
US-20180355242-A1 OXYGEN SENSING DIFLUOROBORON B-DIKETONATE POLYLACTIDE MATERIALS FOR WOUND IMAGING NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-12-13 US disclosed
EP-3386991-A1 POLYCYCLIC COMPOUNDS AS INHIBITORS OF BRUTON'S TYROSINE KINASE Janssen Pharmaceutica NV (BE) 2018-10-17 EP disclosed
US-20180099927-A1 UV-ABSORBING COMPOUNDS WITH AT LEAST ONE REACTIVE HYDROGEN ISP INVESTMENTS LLC (US) 2018-04-12 US disclosed
US-20180099927-A1 UV-ABSORBING COMPOUNDS WITH AT LEAST ONE REACTIVE HYDROGEN ISP INVESTMENTS LLC (US) 2018-04-12 US disclosed
US-20180099927-A1 UV-ABSORBING COMPOUNDS WITH AT LEAST ONE REACTIVE HYDROGEN ISP INVESTMENTS LLC (US) 2018-04-12 US disclosed
WO-2017100662-A1 POLYCYCLIC COMPOUNDS AS INHIBITORS OF BRUTON'S TYROSINE KINASE JANSSEN PHARMACEUTICA NV (BE) 2017-06-15 WO disclosed
WO-2017100764-A1 OXYGEN SENSING DIFLUOROBORON B-DIKETONATE POLYLACTIDE MATERIALS FOR WOUND IMAGING UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2017-06-15 WO disclosed
US-20160002154-A1 UV-ABSORBING COMPOUNDS WITH AT LEAST ONE REACTIVE HYDROGEN ISP INVESTMENTS INC. (US) 2016-01-07 US disclosed
US-20160002154-A1 UV-ABSORBING COMPOUNDS WITH AT LEAST ONE REACTIVE HYDROGEN ISP INVESTMENTS INC. (US) 2016-01-07 US disclosed
US-20160002154-A1 UV-ABSORBING COMPOUNDS WITH AT LEAST ONE REACTIVE HYDROGEN ISP INVESTMENTS INC. (US) 2016-01-07 US disclosed
WO-2014149363-A1 UV-ABSORBING COMPOUNDS WITH AT LEAST ONE REACTIVE HYDROGEN ISP INVESTMENTS INC. (US) 2014-09-25 WO disclosed
US-7955861-B2 Luminescent diketonate polymers UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2011-06-07 US disclosed
US-20090137057-A1 LUMINESCENT DIKETONATE POLYMERS UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2009-05-28 US disclosed
WO-2007143209-A2 LUMINESCENT DIKETONATE POLYMERS UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2007-12-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10351523-B2 UV-absorbing compounds with at least one reactive hydrogen ERCC1, ERCC4, UNG MEN1 450/4885KMT2A 3448/4885L3MBTL1 4053/4885
US-20160002154-A1 UV-ABSORBING COMPOUNDS WITH AT LEAST ONE REACTIVE HYDROGEN ERCC1, ERCC4, UNG MEN1 450/4885KMT2A 3448/4885L3MBTL1 4053/4885
US-20180099927-A1 UV-ABSORBING COMPOUNDS WITH AT LEAST ONE REACTIVE HYDROGEN ERCC1, ERCC4, UNG MEN1 450/4885KMT2A 3448/4885L3MBTL1 4053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.